| 摘要 |
<p>The present invention concerns immunoglobulins, such as antibodies, which specifically bind Oncostatin M (OSM), particularly human OSM (hOSM) and modulate the interaction between OSM and gp130. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.</p> |
